CYP17 gene promoter allelic variant is not associated with prostate cancer

中國醫藥大學機構典藏 China Medical University Repository, Taiwan > 醫學院 > 醫學系 > 期刊論文 > Item 310903500/3680

請使用永久網址來引用或連結此文件: http://ir.cmu.edu.tw/ir/handle/310903500/3680

題名:	CYP17 gene promoter allelic variant is not associated with prostate cancer
作者:	林正介(Cheng-Chieh Lin);吳錫金(Wu,Hsi-Chin);陳汶吉(Chen Wen-Chi);陳慧毅(Huey-Yi Chen);蔡輔仁(Fuu-Jen Tsai)
貢獻者:	醫學院醫學系學士班家庭醫學科;中國附醫社區醫學部家庭醫學科
關鍵詞:	CYP17 gene;Prostate cancer;Cytochrome p450c17α enzyme;Single nucleotide polymorphisms (SNPs)
日期:	2003-07
上傳時間:	2009-08-20 18:49:15 (UTC+8)
摘要:	Prostate cancer is the most common urological malignancy in Taiwan. The formation of prostate cancer has been reported to be associated with androgen. Two key steps in the sex steroid synthesis are mediated by the enzyme cytochrome P450c17α which is encoded in the CYP17 gene. Our aim was to investigate whether a polymorphism of CYP17 gene could be used as a genetic marker for associating prostate cancer. In this study, we compared the frequency of the C/T polymorphism of CYP17 gene 5′-UTR promoter region between 93 patients with prostate cancer and 121 healthy male volunteers (age, >60 years). The result revealed no significant association between the CYP17 genotype and prostate cancer (P = .781). Therefore, CYP17 C/T polymorphism is not a valid genetic marker for prostate cancer. Although a possible interaction between CYP17 gene C/T polymorphism and SP-1 transcription factor has been reported in the literature, we did not find any evidence for this the difference among clinical staging, pathological grading, or responsiveness to hormonal therapy in prostate cancer.
關聯:	UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS 21(4):262~265
顯示於類別:	[醫學系] 期刊論文

文件中的檔案:

檔案	大小	格式	瀏覽次數
	58Kb	Unknown	469	檢視/開啟

在CMUR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....